Welcome to Unichem Bishopdale Pharmacy

The team at Unichem Bishopdale Pharmacy have been proudly providing trusted advice to the Bishopdale community for over 55 years. Our team of experienced professionals are trained to provide tailored recommendations to fit you and the people you care about.

We can safely and efficiently dispense a wide range of medicines, including prescription and non-prescription treatments for the most common of ailments and medical conditions. Come in and see our friendly pharmacists and pharmacy team for all your health and beauty essentials. We look forward to seeing you.

Book a service appointment including vaccinations

We are proud to be able to offer an extensive range of healthcare services to the Bishopdale Community. Some of our services require a booking - please use the link below to do this online. Can't see the service you want to book on the link? Then call us directly at the pharmacy to book. (03) 359 8302 Please see our services tab above for our full range of services.

Click Here

Methyphenidate extended-release supply status January 2025

There remains a New Zealand-wide shortage of extended-release methylphenidate.

Suppliers and wholesalers are limiting the amount of stock going to pharmacies. As such, we may not have any stock. Please be patient.

18 mg – stock of Concerta is due early Feb, stock of Teva brand due end of Jan
27 mg – both brands in stock with restriction
36 mg – stock of Concerta is in stock with restriction, stock of Teva brand is out of stock
54 mg – both brands in stock with restriction

We expect some people may not be able to access their medication and alternative treatments will be needed.

If you are currently taking an extended-release brand of methylphenidate, and your prescribed strength or brand is not available, you will need to talk to your doctor. Your doctor will talk to you about your options, including whether you should be prescribed a different brand of methylphenidate.

There are other brands of methylphenidate available, including long-acting, sustained-release, and immediate release options.

We expect that the supply issues with the Teva and Concerta brands of methylphenidate will last for a while, potentially until the middle of 2025.